Ansa Biotechnologies
DNA Synthesis
1 open roleDNA SynthesisEmeryville, United States127 employees$177M raisedEst. 2018
Northpond Ventures
Cerberus Ventures
Blue Water Life Science Advisors
Altitude Life Science Ventures
Fall Line Capital
AIM13
About Ansa Biotechnologies
- Ansa Biotechnologies is a leading enzymatic DNA synthesis company developing a novel, enzyme-based technology to synthesize DNA.
- This technology aims to be faster, more accurate, and cleaner than existing methods, accelerating innovation in synthetic biology, medicine, agriculture, and industrial biotechnology.
Ansa Biotechnologies is listed on Rocketlist with 1 active role. The company is categorized as DNA Synthesis in BioTech. Ansa Biotechnologies is at Series B stage, with a B2B business model, headquartered in Emeryville, United States. Ansa Biotechnologies was founded in 2018 and has 127 employees. Ansa Biotechnologies has raised $177M. Active roles are refreshed daily from public hiring sources.